- Home
- BLTE vs INDV Comparison
BLTE vs INDV Comparison
Compare BLTE & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLTE | INDV |
|---|---|---|
| Founded | 2018 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.1B |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | BLTE | INDV |
|---|---|---|
| Price | $148.92 | $36.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | ★ $149.00 | $32.50 |
| AVG Volume (30 Days) | 244.0K | ★ 2.0M |
| Earning Date | 11-10-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.98 |
| Revenue | N/A | ★ $1,180,000,000.00 |
| Revenue This Year | N/A | $1.09 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $36.70 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $49.00 | $7.62 |
| 52 Week High | $160.55 | $38.00 |
Technical Indicators
Market Signals| Indicator | BLTE | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 68.29 | 80.75 |
| Support Level | $140.07 | $33.50 |
| Resistance Level | $154.00 | $38.00 |
| Average True Range (ATR) | 12.43 | 1.11 |
| MACD | 0.74 | 0.13 |
| Stochastic Oscillator | 78.20 | 76.88 |
Price Performance
Historical ComparisonAbout BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.
About INDV Indivior PLC
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.